A phase 1 trial of alisertib and romidepsin for relapsed/refractory aggressive B-cell and T-cell lymphomas

door Strati, Paolo, Nastoupil, Loretta J., Davis, Richard E, Fayad, Luis E., Fowler, Nathan, Hagemeister, Fredrick B., Kwak, Larry, Oki, Yasuhiro, Wang, Michael, Westin, Jason, Ruben, Charnelle E., Wesson, Emily T., Piekarz, Richard, Fanale, Michelle A., Lee, Hun Ju
Gepubliceerd in Haematologica (2020)

A phase I study of romidepsin and ifosfamide, carboplatin, etoposide for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma

door Strati, Paolo, Chihara, Dai, Oki, Yasuhiro, Fayad, Luis E, Fowler, Nathan, Nastoupil, Loretta, Romaguera, Jorge E, Samaniego, Felipe, Garg, Naveen, Feng, Lei, Wesson, Emily T., Ruben, Charnelle E., Stafford, Mildred D., Nieto, Yago, Khouri, Issa F, Hosing, Chitra, Horowitz, Sandra B., Kamble, Rammurti T-., Fanale, Michelle A.
Gepubliceerd in Haematologica (2018)